Silent Ischemic Heart Disease and Pericardial Fat Volume in HIV-Infected Patients: A Case-Control Myocardial Perfusion Scintigraphy Study

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Kristoffersen, Ulrik S ^a,b   Lebech, Anne Mette ^c   Wiinberg, Niels ^d   Petersen, Claus L ^d   Hasbak, Philip ^a   Gutte, Henrik ^a,b   Jensen, Gorm B ^c,e   Hag, Anne Mette F ^b   Ripa, Rasmus S ^a,d   Kjaer, Andreas ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; GELATINASE B; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA DIRECTED DNA POLYMERASE INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CT SPECT SCANNER; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; MYOCARDIAL PERFUSION DEFECT; MYOCARDIAL PERFUSION IMAGING; PERICARDIAL FAT VOLUME; SILENT ISCHEMIC HEART DISEASE;

ADIPOSE TISSUE; ANTI-HIV AGENTS; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CALCIUM; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CELL SIZE; CORONARY VESSELS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PERICARDIUM; RISK;

EID: 84881504785     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072066     Document Type: Article

References (35)

1. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV, (2006) Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 145: 397-406.
2. Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, et al. (2011) Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One 6: e22698.
3. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, et al. (1998) Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97: 535-543.
4. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, et al, (2004) Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 90: 1286-1290.
5. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, et al. (2007) Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 21: 1137-1145.
6. Thiebaut R, Aurillac-Lavignolle V, Bonnet F, Ibrahim N, Cipriano C, et al. (2005) Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004. AIDS 19: 729-731.
7. de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, et al. (2008) Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 29: 777-783.
8. Alexopoulos N, McLean DS, Janik M, Arepalli CD, Stillman AE, et al. (2010) Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 210: 150-154.
9. Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, et al. (2010) Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 209: 573-578.
10. Nyboe J, Jensen G, Appleyard M, Schnohr P, (1989) Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Copenhagen City Heart Study. Eur Heart J 10: 910-916.
11. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832.
12. Sacks HS, Fain JN, (2007) Human epicardial adipose tissue: a review. Am Heart J 153: 907-917.
13. Lebech AM, Wiinberg N, Kristoffersen US, Hesse B, Petersen CL, et al. (2007) Carotid intima-media thickness in HIV patients treated with antiretroviral therapy. Clin Physiol Funct Imaging 27: 173-179.
14. Kristoffersen US, Kofoed K, Kronborg G, Benfield T, Kjaer A, et al. (2009) Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy. HIV Med 10: 627-633.
15. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
16. Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, et al. (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17: 491-501.
17. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J, (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12: 295-300.
18. Friis-Moller N, Sabin CA, Weber R, d'Arminio MA, El-Sadr WM, et al. (2003) Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349: 1993-2003.
19. Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, et al. (2010) Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS 24: 1228-1230.
20. Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, et al. (2007) Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 44: 1625-1631.
21. Fitch KV, Lo J, Abbara S, Ghoshhajra B, Shturman L, et al. (2010) Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters. J Acquir Immune Defic Syndr 55: 495-499.
22. Lo J, Abbara S, Shturman L, Soni A, Wei J, et al. (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24: 243-253.
23. Shaw LJ, Iskandrian AE, (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11: 171-185.
24. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, et al. (1998) Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31: 126-133.
25. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC, (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291: 210-215.
26. Pletcher MJ, Tice JA, Pignone M, McCulloch C, Callister TQ, et al. (2004) What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk. BMC Med 2: 31.
27. Lorenz MW, Stephan C, Harmjanz A, Staszewski S, Buehler A, et al. (2008) Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196: 720-726.
28. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, et al. (2009) Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 23: 1841-1849.
29. Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, et al. (2008) Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 22: 1615-1624.
30. Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S (2012) Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J in press.
31. Kaptoge S, Di AE, Lowe G, Pepys MB, Thompson SG, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140.
32. Kristoffersen US, Kofoed K, Kronborg G, Giger AK, Kjaer A, et al. (2009) Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. HIV Med 10: 79-87.
33. Taguchi R, Takasu J, Itani Y, Yamamoto R, Yokoyama K, et al. (2001) Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157: 203-209.
34. Guaraldi G, Scaglioni R, Zona S, Orlando G, Carli F, et al. (2011) Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS 25: 1199-1205.
35. Crum-Cianflone N, Kathiria N, Shauger S, Love K, Boswell G (2012) The Association of Epicardial Adipose Tissue with Coronary Artery Calcification among HIV-Infected Men. AIDS.